5,0
20 mag 2026
Dipendente attuale, più di un anno
Uppal
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
The company in terms of its services/products and global reach is amazing. Excelra possesses premium datasets for Drug Discovery which include GOSTAR and GOBIOM.
Svantaggi
There are no cons as I have seen in this company